| Date Filed | Type | Description |
| 05/25/2023 |
4
| Lyons-Williams Lori (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 12,940 options to buy
@ $20.93, valued at
$270.8k
|
|
| 05/26/2022 |
4
| Lyons-Williams Lori (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 8,500 options to buy
@ $13.64, valued at
$115.9k
|
|
| 11/10/2021 |
4
| Lyons-Williams Lori (Director) has filed a Form 4 on RAPT Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $38.28, valued at
$861.3k
|
|
| 11/10/2021 |
3
| Lyons-Williams Lori (Director) has filed a Form 3 on RAPT Therapeutics, Inc. |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2019 |
4
| Lyons-Williams Lori (Chief Commercial Officer) has filed a Form 4 on Dermira, Inc.|
Txns:
| Paid exercise price by delivering 1,582 shares
@ $7.91, valued at
$12.5k
Exercised 3,189 restricted stock units
@ $0 |
|
| 06/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/21/2019 |
4
| Lyons-Williams Lori (Chief Commercial Officer) has filed a Form 4 on Dermira, Inc.|
Txns:
| Paid exercise price by delivering 10,374 shares
@ $10.5, valued at
$108.9k
Exercised 30,000 restricted stock units
@ $0 |
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2018 |
4
| Lyons-Williams Lori (Chief Commercial Officer) has filed a Form 4 on Dermira, Inc.|
Txns:
| Paid exercise price by delivering 368 shares
@ $9.58, valued at
$3.5k
Granted 60,000 restricted stock units
@ $0
Exercised 1,063 restricted stock units
@ $0 |
|
| 02/16/2018 |
4
| Lyons-Williams Lori (Chief Commercial Officer) has filed a Form 4 on Dermira, Inc.|
Txns:
| Granted 63,750 options to buy
@ $28.25, valued at
$1.8M
Granted 10,630 restricted stock units
@ $0 |
|
| 01/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |